Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Seeks Suggestions On Hastening E-Health Record Interoperability, Data Exchange

This article was originally published in The Pink Sheet Daily

Executive Summary

Hinting that the electronic health record incentive program is not resulting in quick-enough adoption of interoperable systems, HHS asks for suggestions on how to speed up the process of making EHRs interoperable, as well as to get providers to utilize health information exchange.

You may also be interested in...



CMS Eyes Payment Incentives To Drive E-Health Information Exchange

An agency white paper on how HHS, CMS and the Office of the National Coordinator for Health Information Technology plan to accelerate health information exchange acknowledges a current lack of financial incentives to encourage exchange of data.

Pausing E-Health Record Meaningful Use Incentives Would Stall Progress, HHS Official Says

Any pause in the current electronic health record meaningful use incentive program could stall momentum on EHR adoption, HHS National Coordinator for Health IT Mostashari tells the Senate Finance Committee.

Questions On Financing Electronic Health Info Exchange Obscure Its Future, Report Says

Realizing the full potential of the growing electronic health record adoption depends on robust health information exchange, according to a report by the Robert Wood Johnson Foundation. But in order to get there, questions on how HIE is financed need to be addressed.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS075493

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel